$LVO

LiveOne, Inc. (LVO): Entry into a Material Definitive Agreement

LiveOne, Inc. (LVO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ea029947301ex10-1.htm SHARES ISSUANCE AGREEMENT, DATED AS OF JULY 22, 2026, BY AND BETWEEN THE COMPANY AND MUSIC STORY SAS Exhibit 10.1 SHARES ISSUANCE AGREEMENT This SHARES ISSUANCE AGREEMENT (this “Agreement”), dated as of July 22, 2026 (the “Effective Date”), is by a

Original reporting
Published Jul 28, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$LVO
Neutral
medium confidence
Mentioned
$LVO
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LVONeutralLow
01

Why it matters

LiveOne will issue 70,000 shares to Music Story to compensate for outstanding fees and extend the underlying agreement through February 24, 2028. The counterparty’s ability to sell shares is governed by daily trading caps, ROFR, and VWAP/discount rules for block trades, which can create a modest near-term overhang.

02

Market read

Traders may monitor for dilution/selling overhang and for any subsequent disclosures about the sales activity under the ROFR and monthly notice framework.

03

What to watch

The agreement includes ROFR timing and VWAP-based sale constraints, which may reduce immediate selling pressure; the excerpt also references a potential monthly cash payment maximum if sales fall below a threshold, which could alter counterparty incentives.

Relevance 6/10Novelty 5/10Timing: after-hours filing of a new 8-K shares issuance agreement (filed 2026-07-28)

Background

The 8-K discloses Item 1.01 entry into a Shares Issuance Agreement dated July 22, 2026, between LiveOne, Slacker, and Music Story SAS, tied to past-due fees under a February 24, 2022 metadata license and service agreement.

Company-level read

Ticker impact

$LVONeutralMedium confidence
Context

LiveOne entered a material definitive shares issuance agreement with Music Story to settle past-due fees via 70,000 LVO common shares and extend the metadata agreement to 2028.

Expected impact

Likely limited price impact, but could add overhang if the counterparty sells shares under the ROFR and VWAP/discount block-trade provisions.

Evidence & confidence

The 8-K is a primary disclosure of a defined share issuance (70,000 shares) and a structured sales process (open market with daily cap, block trades with discount limits, and ROFR). The excerpt does not provide the dollar value of the outstanding fees or the size of any broader financing, so magnitude is uncertain.

Market effects

Limited read-across to the broader music-tech or digital rights licensing space; this is primarily company-specific contract settlement and extension.

No clear regional spillover beyond US-listed LiveOne.

Minimal global relevance; involves a France-based counterparty but the disclosed impact is on LiveOne’s capital structure and fee settlement.

Counterpoint

Because the issuance is small (70,000 shares) and tied to settling past-due fees, the net effect may be closer to balance-sheet cleanup than meaningful dilution.

Key entities

  • LiveOne, Inc.

    US-listed company entering the shares issuance agreement and extending the metadata license/service agreement.

  • Music Story SAS

    France-based company receiving 70,000 shares in exchange for accepting settlement of outstanding fees and extending the agreement.

  • Slacker, Inc.

    Delaware corporation included in the agreement, jointly and severally responsible for certain cash payment obligations described in the excerpt.

Related articles

$LVOMed

LiveOne, Inc. (LVO): Results of Operations and Financial Condition

LiveOne, Inc. (LVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030172301ex99-1.htm PRESS RELEASE, DATED AUGUST 12, 2026 Exhibit 99.1 LiveOne (Nasdaq: LVO) Delivers Record Q1 Fiscal 2027 Results with $19.4 Million Revenue and $4.3 Million Adjusted EBITDA; PodcastOne Posts Record $16.1 Million Revenue LOS ANGELES, August 12, 2026 -

$LVOHigh

LiveOne, Inc. (LVO): Results of Operations and Financial Condition

LiveOne, Inc. (LVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029577201ex99-1.htm PRESS RELEASE, DATED JUNE 24, 2026 Exhibit 99.1 LiveOne (Nasdaq: LVO) Delivers Strong Fiscal 2026 Performance with $77.1M Revenue; Audio Division Drives Growth with $73.5M Revenue and $6.1M+ Adjusted EBITDA*; Raises Fiscal 2027 Outlook Q4 Momentum

$LVOMedAI 8/10

LiveOne (Nasdaq: LVO) Doubles Down on Partnership with Tesla and AI Marketing to Increase ARPUs and Convert 1.1M+ Free Subscribers into Paid Users

LiveOne (Nasdaq: LVO) said it is expanding AI-driven marketing to convert 1.1 million+ free subscribers into paid users, citing engagement of over 59 minutes daily and improving subscriber trends for two months. The plan includes converting Tesla dashboard users via LiveOne’s in-vehicle app (500+ music channels, 200+ podcasters) and AI marketing initiatives using tools and partners including Claude, Meta, LiveRamp, Jasper, and others.

$CMCSAMed

Comcast Soars 20% on NBCUniversal Spinoff News

Comcast said June 29, 2026 it will split into two separate publicly traded companies, separating its connectivity business from NBCUniversal and Sky media assets. The plan is expected to take about a year, targeting mid-2027, and is structured as a tax-free spinoff. Comcast’s shares rose about 20% on the news.

$TSNMed

Tyson Foods to Close Beef Plants Amid Cattle Shortage

Tyson Foods said it will close or sell three US beef plant and packaging sites due to a cattle shortage and deeper losses. It will end operations in Joslin, Illinois, and Eagle Mountain, Utah, and pursue a sale of the Pasco, Washington plant, moving capacity to Dakota City, Nebraska; Holcomb, Kansas; and Amarillo, Texas, Reuters reported.

$IPHAMed

Innate Pharma Secures €30M, Extends Cash Runway Into 2028

Innate Pharma (NASDAQ:IPHA) completed enrollment in the dose-escalation portion of its Phase I trial of IPH4502, enrolling 76 patients by July 21. The company expects 10 to 15 patients at go-forward doses across post-PADCEV urothelial cancer, head and neck cancer, and NSCLC, with dose-escalation data later in 2024. Innate also awaits primary-endpoint data from AstraZeneca’s PACIFIC-9 monalizumab study by year-end, after a €30M financing extending its cash runway into 2028.